Societal Cdmo Inc (SCTL) Gross Profit Margin starting from the fourth quarter 2023 to fourth quarter 2022, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Societal Cdmo Inc   (NASDAQ: SCTL)


Societal Cdmo Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SCTL Gross Profit Margin (Dec 31 2023)
Q4 		(Sep 30 2023)
Q3 		(Jun 30 2023)
Q2 		(Mar 31 2023)
Q1 		(Dec 31 2022)
Q4
Y / Y Revenue Change 14.17 %
Seq. Revenue Change 17.5 %
Revenue In Millions $27.72
Gross Profit Margin 27.77 %
Gross Profit Margin Total Ranking # 2847
Gross Profit In Millions $7.70
Y / Y Gross Profit Change 12.51 %
Seq. Gross Profit Change 106.94 %


Commenting fourth quarter 2023 Gross Profit Margin
Societal Cdmo Inc Gross Profit grew by 106.94 % in Q4 sequentially to 8 millions, while Revenue increased by 17.5 %, this led to improvement in the company's Gross Profit Margin to 27.77 %, Gross Profit Margin remained below Societal Cdmo Inc average.


Observing fourth quarter 2023 results within Major Pharmaceutical Preparations industry 151 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 2847, from total ranking in the previous quarter at 3381.
Learn about Gross Margin
SCTL's Gross Profit Margin fourth quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 152
Healthcare Sector # 451
Overall # 2812

Gross Profit Margin Statistics
High Average Low
66.11 % 36.3 % 10.44 %
(Sep 30 2016)   (Mar 31 2023)


SCTL Gross Income Trends • More of SCTL's Profitabilty Ratios • SCTL Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
SCTL's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
SCTL's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for SCTL's Competitors
Gross Profit Margin Profit Margin for Societal Cdmo Inc 's Suppliers
Gross Profit Margin Profit Margin for SCTL's Customers

You may also want to know
SCTL's Annual Growth Rates SCTL's Profitability Ratios SCTL's Asset Turnover Ratio SCTL's Dividend Growth
SCTL's Roe SCTL's Valuation Ratios SCTL's Financial Strength Ratios SCTL's Gross Profit Growth
SCTL's Roa SCTL's Inventory Turnover Ratio SCTL's Growth Rates SCTL's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Gross Profit MarginDec 31 2023 MRQ Gross ProfitDec 31 2023 MRQ Revenue
Scisparc Ltd  76.28 %$ 2.196  Millions$ 2.879  Millions
Bristol myers Squibb Company  76.08 %$ 8,732.000  Millions$ 11,477.000  Millions
Theratechnologies Inc   75.99 %$ 62.129  Millions$ 81.764  Millions
Phathom Pharmaceuticals Inc   75.51 %$ 0.515  Millions$ 0.682  Millions
Morphosys Ag  75.51 %$ 201.515  Millions$ 266.872  Millions
Durect Corp  75.35 %$ 2.011  Millions$ 2.669  Millions
Harmony Biosciences Holdings inc   74.35 %$ 125.260  Millions$ 168.472  Millions
Novartis Ag  73.27 %$ 34,188.000  Millions$ 46,660.000  Millions
Merck and Co Inc   73.26 %$ 10,719.000  Millions$ 14,631.000  Millions
Aytu Biopharma Inc  72.98 %$ 16.203  Millions$ 22.203  Millions
Organogenesis Holdings Inc   72.13 %$ 71.882  Millions$ 99.651  Millions
Keenova Therapeutics Plc  72.09 %$ 586.200  Millions$ 813.200  Millions
Bausch Health Companies Inc   71.14 %$ 1,713.000  Millions$ 2,408.000  Millions
Scpharmaceuticals Inc   70.92 %$ 4.323  Millions$ 6.096  Millions
Heron Therapeutics Inc   70.91 %$ 24.348  Millions$ 34.336  Millions
Nature s Sunshine Products inc   70.80 %$ 78.323  Millions$ 110.631  Millions
Assertio Holdings inc   70.53 %$ 23.264  Millions$ 32.985  Millions
Earth Science Tech Inc   70.39 %$ 2.377  Millions$ 3.377  Millions
Jaguar Health Inc   70.13 %$ 1.613  Millions$ 2.300  Millions
Nektar Therapeutics  69.51 %$ 16.602  Millions$ 23.885  Millions
Sanofi  69.35 %$ 36,072.960  Millions$ 52,016.960  Millions
Harrow Inc   68.91 %$ 25.053  Millions$ 36.355  Millions
Evolus Inc   68.41 %$ 41.729  Millions$ 60.999  Millions
Johnson and Johnson  68.23 %$ 14,597.000  Millions$ 21,395.000  Millions
Zoetis Inc   67.10 %$ 1,485.000  Millions$ 2,213.000  Millions
Akebia Therapeutics Inc   65.45 %$ 36.702  Millions$ 56.074  Millions
Igc Pharma Inc   65.20 %$ 0.133  Millions$ 0.204  Millions
Aquestive Therapeutics Inc   64.57 %$ 8.527  Millions$ 13.206  Millions
Medicure Inc   64.48 %$ 10.716  Millions$ 16.618  Millions
Collegium Pharmaceutical Inc   63.19 %$ 94.630  Millions$ 149.745  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.